• EMA Says Sinus Bradycardia a Possible Risk With Remdesivir

    1 day ago - By Medscape

    A causal relationship between COVID-19 treatment with remdesivir and sinus bradycardia is 'at least a reasonable possibility,' the EMA's safety committee has concluded.
    News Alerts
    Read more ...